SCHEMBL2719944

SCHEMBL2719944

CCCC(=O)OC(CC)CC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
MAPT P10636 3/20 0.50
MAPK1 P28482 3/20 0.50
LMNA P02545 5/20 0.47
PRKCA P17252 1/20 0.43
PRKCE Q02156 1/20 0.43
PRKCQ Q04759 1/20 0.43
PRKCD Q05655 1/20 0.43
CYP1A2 P05177 3/20 0.41
MEN1 O00255 1/20 0.40
GMNN O75496 1/20 0.40
HSP90AA1 P07900 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
FAAH O00519 1/20 0.40
HPGD P15428 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10553245 0.90 MAPT (0.48) ALDH1A1MAPTMAPK1LMNAPRKCA
SCHEMBL4347723 0.89 ALDH1A1 (0.46) ALDH1A1MAPTMAPK1LMNAPRKCA
SCHEMBL8973706 0.89 MAPT (0.60) ALDH1A1MAPTMAPK1LMNAPRKCA
SCHEMBL10283328 0.86 MAPT (0.62) ALDH1A1MAPTMAPK1LMNAPRKCA
SCHEMBL10551514 0.85 MAPT (0.55) ALDH1A1MAPTMAPK1LMNAPRKCA
SCHEMBL247870 0.85 MAPK1 (0.61) ALDH1A1MAPTMAPK1LMNAPRKCA
SCHEMBL23810002 0.85 ALDH1A1 (0.43) ALDH1A1MAPTMAPK1LMNAPRKCA
SCHEMBL14871951 0.85 CYP1A2 (0.54) ALDH1A1MAPTMAPK1LMNAPRKCA
SCHEMBL25518095 0.85 ALDH1A1 (0.43) ALDH1A1MAPTMAPK1LMNAPRKCA
SCHEMBL14199965 0.85 ALDH1A1 (0.62) ALDH1A1LMNAPRKCAPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250178997-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2025-06-05 US disclosed
EP-4490139-A1 ORGANIC COMPOUNDS Givaudan SA (CH) 2025-01-15 EP disclosed
CN-118317944-A Acyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-07-09 CN disclosed
WO-2023170192-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2023-09-14 WO disclosed
CN-109952360-B Quantum dot dispersion, self-luminous photosensitive resin composition, color filter manufactured using the same, and image display device 东友精细化工有限公司 2022-03-22 CN disclosed
EP-2629889-B1 RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF YEDA RES & DEV (IL) 2019-04-03 EP disclosed
US-9738685-B2 Use of ruthenium complexes for preparing amides, polypeptides and cyclic dipeptides YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2017-08-22 US disclosed
US-9738685-B2 Use of ruthenium complexes for preparing amides, polypeptides and cyclic dipeptides YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2017-08-22 US disclosed
US-9738685-B2 Use of ruthenium complexes for preparing amides, polypeptides and cyclic dipeptides YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2017-08-22 US disclosed
US-20170107251-A1 NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2017-04-20 US disclosed
US-20130281664-A1 NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2013-10-24 US disclosed
US-20130281664-A1 NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2013-10-24 US disclosed
US-20130281664-A1 NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2013-10-24 US disclosed
EP-2629889-A2 NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF Yeda Research and Development Co. Ltd. (IL) 2013-08-28 EP disclosed
US-20120253042-A1 USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2012-10-04 US disclosed
US-20120253042-A1 USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2012-10-04 US disclosed
US-20120253042-A1 USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2012-10-04 US disclosed
WO-2012052996-A2 NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2012-04-26 WO disclosed
WO-2012052996-A2 NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2012-04-26 WO disclosed
CN-101108849-A Benzo 58743 TOKUYAMA CORP (JP) 2008-01-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170107251-A1 NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF ADH1C, ADH5, ADH1A ALDH1A1 1757/4885MAPT 3796/4885MAPK1 4093/4885
US-20120253042-A1 USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES ADH5, ADH1C, ADH1A ALDH1A1 197/4885MAPT 3690/4885MAPK1 3329/4885
US-20250178997-A1 ORGANIC COMPOUNDS ODC1, LMAN1, OSBP ALDH1A1 14/4885MAPT 3113/4885MAPK1 2298/4885
US-20130281664-A1 NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF ADH5, ADH1C, ADH1A ALDH1A1 1796/4885MAPT 3645/4885MAPK1 4394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.